MAM
PFE icon

Marotta Asset Management’s Pfizer PFE Stock Holding History

Marotta Asset Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$238K Hold
4,647
– – 0.06% 94
2022
Q3 		$203K Hold
4,647
– – 0.05% 100
2022
Q2 		$243K Hold
4,647
– – 0.06% 98
2022
Q1 		$241K Hold
4,647
– – 0.06% 100
2021
Q4 		$274K Buy
+4,647
New +$230K 0.06% 92

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marotta Asset Management's PFE Position: Q4 2022 in Review

Marotta Asset Management held its Pfizer (PFE) position steady in Q4 2022 at 4,647 shares worth $238K. The position accounts for 0.06% of the portfolio, ranked #94.

Marotta Asset Management first reported a position in PFE in Q4 2021 and has held it in 5 quarters since. The position peaked at $274K in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Marotta Asset Management held 4,647 shares of Pfizer worth $238K as of Q4 2022.
  • Marotta Asset Management left its Pfizer share count unchanged in Q4 2022.
  • Pfizer made up 0.06% of Marotta Asset Management's portfolio in Q4 2022, its #94 holding.
  • Marotta Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 5 quarters since.
  • Marotta Asset Management's Pfizer position peaked at $274K in Q4 2021.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Marotta Asset Management's 13F filing for Q4 2022, filed 3 Jan 2023.